These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Image-guided biopsy: what the interventional radiologist needs to know about PET/CT. Kobayashi K; Bhargava P; Raja S; Nasseri F; Al-Balas HA; Smith DD; George SP; Vij MS Radiographics; 2012; 32(5):1483-501. PubMed ID: 22977031 [TBL] [Abstract][Full Text] [Related]
23. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues. Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845 [TBL] [Abstract][Full Text] [Related]
24. Special Techniques in PET/Computed Tomography Imaging for Evaluation of Head and Neck Cancer. Kumar R; Mukherjee A; Mittal BR PET Clin; 2016 Jan; 11(1):13-20. PubMed ID: 26590440 [TBL] [Abstract][Full Text] [Related]
25. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review. Treglia G; Annunziata S; Sobic-Saranovic D; Bertagna F; Caldarella C; Giovanella L Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482 [TBL] [Abstract][Full Text] [Related]
26. [Detection of pulmonary tumor thrombosis by integrated 18F-FDG PET/CT scans with intravenous contrast]. Valls E; Garcia JR; Rodriguez R; Soler M; Moragas M; Lomeña F Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):49-51. PubMed ID: 23177345 [No Abstract] [Full Text] [Related]
27. [Positron emission tomography-computed tomography in tumors of the locomotor apparatus]. Gámez Cenzano C; Sabaté Llobera A; Narváez García JA; Rodríguez Bel L; García del Muro FJ Radiologia; 2012 Sep; 54 Suppl 1():3-13. PubMed ID: 22959330 [TBL] [Abstract][Full Text] [Related]
28. Role of 2-Deoxy-2-[18F]-fluoro-d-glucose-PET/Computed Tomography in Lymphoma. Tirumani SH; LaCasce AS; Jacene HA PET Clin; 2015 Apr; 10(2):207-25. PubMed ID: 25829087 [TBL] [Abstract][Full Text] [Related]
29. Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma? van Hamersvelt HP; Kwee TC; Fijnheer R; Beek FJ; de Klerk JM; Nievelstein RA J Comput Assist Tomogr; 2014; 38(4):620-5. PubMed ID: 24681861 [TBL] [Abstract][Full Text] [Related]
30. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy. Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091 [TBL] [Abstract][Full Text] [Related]
32. Pelvis: normal variants and benign findings in FDG-PET/CT imaging. Kohan A; Avril NE PET Clin; 2014 Apr; 9(2):185-93. PubMed ID: 25030281 [TBL] [Abstract][Full Text] [Related]
33. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer? Schaefferkoetter JD; Carlson ER; Heidel RE J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746 [TBL] [Abstract][Full Text] [Related]
34. Usefulness of dual-phase 18F-FDG PET/CT for diagnosing small pancreatic tumors. Kawada N; Uehara H; Hosoki T; Takami M; Shiroeda H; Arisawa T; Tomita Y Pancreas; 2015 May; 44(4):655-9. PubMed ID: 25815646 [TBL] [Abstract][Full Text] [Related]
35. Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer. Ciarallo A; Marcus C; Taghipour M; Subramaniam RM PET Clin; 2015 Apr; 10(2):265-78. PubMed ID: 25829091 [TBL] [Abstract][Full Text] [Related]
36. The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis. Hu S; Zhang J; Cheng C; Liu Q; Sun G; Zuo C Abdom Imaging; 2014 Dec; 39(6):1221-7. PubMed ID: 24913670 [TBL] [Abstract][Full Text] [Related]
37. Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET/CT: a potential pitfall of standard-field imaging. Kaneuchi Y; Hakozaki M; Yamada H; Hasegawa O; Tajino T; Konno S Hell J Nucl Med; 2016; 19(1):46-8. PubMed ID: 26929940 [TBL] [Abstract][Full Text] [Related]
38. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle. Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129 [TBL] [Abstract][Full Text] [Related]
39. Determination of vitality of liver lesions by alveolar echinococcosis. Comparison of parametric contrast enhanced ultrasound (SonoVue®) with quantified 18F-FDG-PET-CT. Kaltenbach TE; Graeter T; Mason RA; Kratzer W; Oeztuerk S; Haenle MM; Gruener B; Gottstein M Nuklearmedizin; 2015; 54(1):43-9. PubMed ID: 25423884 [TBL] [Abstract][Full Text] [Related]
40. Potential role of FDG PET/CT in evaluating patients with hepatic incidentalomas. Grassetto G; Marzola MC; Chondrogiannis S; Maffione AM; Rampin L; Galeotti F; Colletti PM; Rubello D Clin Nucl Med; 2014 Feb; 39(2):156-9. PubMed ID: 24321829 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]